Venus Medisurge Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-06-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.30 Cr
as on 16-06-2024
- Revenue 2.96%
(FY 2023)
- Profit -44.06%
(FY 2023)
- Ebitda -23.71%
(FY 2023)
- Net Worth 4.29%
(FY 2023)
- Total Assets 8.31%
(FY 2023)
About Venus Medisurge
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹9.30 Cr.
Sumit Kapadia, Mitesh Shah, Rakeshkumar Luhana, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ2011PTC064645
- Company No.
064645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2011
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Venus Medisurge Private Limited offer?
Venus Medisurge Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Venus Medisurge?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Kapadia  | Director | 28-Mar-2011 | Current |
| Mitesh Shah | Director | 28-Mar-2011 | Current |
| Rakeshkumar Luhana | Director | 28-Mar-2011 | Current |
| Maulesh Dholakia | Director | 28-Mar-2011 | Current |
| Rakesh Patel | Director | 28-Mar-2011 | Current |
Financial Performance of Venus Medisurge.
Venus Medisurge Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.96% increase. The company also saw a substantial fall in profitability, with a 44.06% decrease in profit. The company's net worth moved up by a moderate rise of 4.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Medisurge?
In 2023, Venus Medisurge had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 Sep 2011 | ₹4.65 Cr | Open |
Bank Of India Creation Date: 29 Aug 2011 | ₹4.65 Cr | Open |
How Many Employees Work at Venus Medisurge?
Venus Medisurge has a workforce of 63 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Medisurge, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Medisurge's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
